NexgenRx Inc.
TSX VENTURE : NXG

NexgenRx Inc.

August 19, 2015 12:13 ET

NexgenRx Announces Second Quarter of 2015 Results

TORONTO, ONTARIO--(Marketwired - Aug. 19, 2015) - NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to announce its second quarter of 2015 results.

For the second quarter ended June 30, 2015 transaction and administration revenue was $1,171,611 generating gross profit of $929,672.

"We generated positive operating cash-flow of $211,867 in the first six months of 2015. Net income was $109,306 in Q2, 2015 after a one-time gain. Focus during the quarter was on continued sales growth and a major improvement to the balance sheet." stated Ron Loucks, President and CEO.

NEXGENRX INC. ("NexgenRx" or the "Corporation") also announces the retirement of F. Gregory Thompson from his position as a director of the Corporation.

"On behalf of the Board of Directors, I would like to thank Mr. Thompson for his excellent contribution to the board and his advice and counsel to me during his 10 year term." stated Ron Loucks, President and CEO.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at www.nexgenrx.com.

Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release."

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    416.695.3393 x801

    NexgenRx Inc.
    Taba Merrikh
    Director of Finance
    416-695-3393 x803